Starpharma Holdings Limited
SPHRF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -40.7% | 90.9% | -15.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 75.1% | 92.4% | 28.1% | 36.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -222.5% | -116.2% | -392.4% | -322.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -203.4% | -98.5% | -360.1% | -312.9% |
| EPS Diluted | -0.024 | -0.02 | -0.038 | -0.04 |
| % Growth | -20.7% | 48.2% | 3.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |